Click for stock quote
 






OVERVIEW
CEO MESSAGES
NEWS RELEASES
FINANCIAL REPORTS
SEC & SEDAR FILINGS
CONFERENCES & WEBCASTS
FAQ
CORPORATE GOVERNANCE
CONTACT INFORMATION


News Release Archives

 

2009

2008

2007

2006

2005

2004
2003
2002
2001
2000
1999
1998
1997
1996

HOME » INVESTORS: NEWS RELEASES


 

2008 NEWS RELEASES

 

Monday December 29, 2008 (PDF) - MIGENIX Announces filing of Preliminary Prospectus for Rights Offering to Shareholders

 

Monday, December 15th, 2008  (PDF) - MIGENIX Reports Second Quarter Fiscal 2009 Financial Results

 

Friday, October 24th, 2008 (PDF) - MIGENIX to Present Posters on Novel Lipopeptide at the 2008 ICAAC/IDSA Joint Meeting

Click Here for Posters

 

Friday, October 10, 2008 (PDF) - Corporate Update

 

Monday, September 15, 2008 (PDF) - MIGENIX Reports First Quarter Fiscal 2009 Financial Results

 

Monday, August 11, 2008 (PDF) - MIGENIX Averts Proxy Contest; Reaches Agreement with DJohnson Holdings

 

Thursday, July 24, 2008 (PDF) - Notice of MIGENIX General Meeting of Shareholders

 

Monday, July 21, 2008 (PDF) - MIGENIX Reports Fourth Quarter and Fiscal Year 2008 Financial Results

 

Friday, July 18, 2008 (PDF) - MIGENIX Fourth Quarter and Fiscal Year 2008 Financial Results Conference Call & Webcast

 

Tuesday, July 8, 2008 (PDF) - MIGENIX Corporate Update and Requisition of Special Meeting

 

Tuesday, May 27, 2008 (PDF) - MIGENIX Takes Operational Actions to Extend Cash Past Upcoming Key Milestones

 

Tuesday, May 06, 2008 (PDF) - Omigard™ Phase III Pivotal Registration Study Enrollment Completed

 

Monday, April 21, 2008 (PDF) - MIGENIX Appoints Pieter Dorsman to Board of Directors

 

Thursday, March 13, 2008 (PDF) - MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results

 

Tuesday, March 11, 2008 (PDF) - MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification

 

Friday, February 15, 2008 (PDF) - MIGENIX Releases CEO Message #22

Thursday, January 31, 2008 (PDF) - MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study

 



© 1996 - 2009 MIGENIX Inc.
Privacy      Legal Disclaimer